The pressure to move quickly in the face of a global pandemic with multiple lines of operation across borders, vaccine procurement, therapeutics and all of the other aspects of a public health response meant that insufficient attention was paid to the governance structure of this project, which we regret and which we have undertaken to rectify in the future.
